ERD

Plasma HER2 ( ERBB2 ) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Preclinical models for precision oncology

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Pooled Analysis of Clinical Outcome of Patients with Chemorefractory Metastatic Colorectal Cancer Treated within Phase I...

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Toxicity of oxaliplatin rechallenge in metastatic colorectal cancer

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Parallel Evaluation of Circulating Tumor DNA and Circulating Tumor Cells in Metastatic Colorectal Cancer

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

A Computational Workflow Translates a 58-Gene Signature to a Formalin-Fixed, Paraffin-Embedded Sample-Based Companion Di...

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Failure is not final: ctDNA-guided rechallenge therapy in colorectal cancer

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

How liquid biopsies can change clinical practice in oncology

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metasta...

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

The Clinical Impact of the Genomic Landscape of Mismatch Repair–Deficient Cancers

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

New clinical trial designs in the era of precision medicine

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Early-onset colorectal cancer in young individuals

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based thera...

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Sequential HER2 blockade as effective therapy in chemorefractory, HER2 gene-amplified, RAS wild-type, metastatic colorec...

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therap...

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review...

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in me...

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Tumor Evolution as a Therapeutic Target

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Tracking colorectal cancer evolution in time and space

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Submission of scientific paper for publication and thereby bringing trial results into the public domain CT3

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Resources

Selected filters:

Plasma HER2 ( ERBB2 ) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer

Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer

Preclinical models for precision oncology

Pooled Analysis of Clinical Outcome of Patients with Chemorefractory Metastatic Colorectal Cancer Treated within Phase I...

Toxicity of oxaliplatin rechallenge in metastatic colorectal cancer

Parallel Evaluation of Circulating Tumor DNA and Circulating Tumor Cells in Metastatic Colorectal Cancer

A Computational Workflow Translates a 58-Gene Signature to a Formalin-Fixed, Paraffin-Embedded Sample-Based Companion Di...

Failure is not final: ctDNA-guided rechallenge therapy in colorectal cancer

How liquid biopsies can change clinical practice in oncology

Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers

Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metasta...

The Clinical Impact of the Genomic Landscape of Mismatch Repair–Deficient Cancers

New clinical trial designs in the era of precision medicine

Early-onset colorectal cancer in young individuals

Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based thera...

Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases

Sequential HER2 blockade as effective therapy in chemorefractory, HER2 gene-amplified, RAS wild-type, metastatic colorec...

Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer

Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therap...

Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review...

SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo

Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in me...

Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer

ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer

BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives

Tumor Evolution as a Therapeutic Target

Tracking colorectal cancer evolution in time and space

Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth

Submission of scientific paper for publication and thereby bringing trial results into the public domain CT3

A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin